Skip to content

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry and Validation of C2D2 (Critical Care Data Dictionary)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04323787
Acronym
COVID-19
Enrollment
100000
Registered
2020-03-27
Start date
2020-03-30
Completion date
2025-03-31
Last updated
2025-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus

Keywords

COVID19

Brief summary

Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.

Detailed description

Investigators aim is to create a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals. Such a set of standards would increase the quality of single and multi-center studies, national registries as well as aggregation syntheses such as meta-analyses. It will also be of utmost importance in tiring times of public health emergencies and will help understand practice variability and outcomes during COVID-19 pandemic.

Interventions

OTHERobservational

No Intervention

Sponsors

Society of Critical Care Medicine
CollaboratorOTHER
Boston University
CollaboratorOTHER
Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* COVID-19 PCR positive (within 7 days) * COVID-19 PCR pending * COVID-19 high clinical suspicion

Exclusion criteria

* Patient without Prior Research Authorization (applicable to Mayo Clinic sites) * Non COVID-19 related admissions * Repeated Admission to ICUs/Hospital

Design outcomes

Primary

MeasureTime frameDescription
ICU and hospital mortality of COVID-19 patients7 daysPrimary outcome will be to measure ICU and hospital mortality up to 7 days of COVID-19 patients

Secondary

MeasureTime frameDescription
30 days mortality30 daysSecondary outcome will be to measure 30 days mortality from Hospital discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026